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Inflammatory myofibroblastic tumors (IMTs) mainly occur in children and young adults, usually in the first two
decades of life. IMT-type tumors belong to neoplasms of an intermediate biologic potential with considerable rate
of local recurrence and in some cases that able to create metastases. Presented case is the first IMT coexisting with
the other neoplasm. In our paper we are going to present a peculiar case of an IMT of the bladder coexisting with
an ovarian teratoma, and to discuss its pathogenesis, histological picture and differential diagnosis. A 19-year-old
female was admitted to the Gynecological Department and during the surgery, two independent, non-adjacent
tumors were found. To settle the diagnosis, a FISH examination with the ALK1 break apart probe was carried out. It
confirmed the rearrangement of the chromosome 2p23. Morphologic and immunophenotypic similarities between
an IMT and other malignant tumors of the bladder may lead to diagnostic errors and an unnecessary radical
cystectomy as a result. The therapy of choice is only total excision of the tumor.
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Inflammatory myofibroblastic tumors (IMTs) mainly occur
in children and young adults, usually in the first two de-
cades of life. The most frequent sites of these tumors
are the lungs, the peritoneum and the mesentery [1,2].
IMTs are very rarely localized in the bladder, so they
need to be differentiated from other bladder tumors [3],
mainly rhabdomyosarcomas and leiomyosarcomas.
Tumors of non-epithelial origin account for about 2-5%
of all neoplasmatic tumors of the bladder: rhabdomyosar-
comas appear most frequently in children under the age
of ten, while leiomyosarcomas are most frequent in adults
[4]. In our paper we are going to present a peculiar case
of an IMT coexisting with an ovarian teratoma, and dis-
cuss its pathogenesis, histological picture and differential
diagnosis.* Correspondence: dobrosz.zuza@vp.pl
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A 19-year-old female was admitted to the Gynecological
Department of the Municipal Hospital due to 3-month-
long pain in the hypogastrium. An ultrasonographic study
revealed a tumor on the left ovary corresponding to a tera-
toma with hypoechogenic structure; it just seemed that
the tumor infiltrated the wall of the bladder and grew into
its lumen. However, during the surgery, two independent,
non-adjacent tumors were found. One of these was a
tumor on the left ovary, 45 mm in diameter. The tumor
had a well-defined capsule, and macroscopically was diag-
nosed as a teratoma. The second lesion was a hard tumor
30 × 40 mm, well circumscribed, which was deforming
the anterior wall of the bladder, and growing into its
lumen. The left appendices and the uterus were normal.
An insignificant amount of transudate fluid was found
on the pelvic floor. The affected ovary was excised, and
then, the anterior wall of the bladder was incised and a
solid tumor of 40 × 30 mm was removed.
Histologically, the bladder tumor was well circum-
scribed and built of bundles of spindle cells divided byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 HE staining.
Figure 2 Calponine staining.
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http://www.diagnosticpathology.org/content/9/1/138abundant amounts of myxoid extracellular matrix. The
tumor cells featured long cytoplasmatic processes and
vesicular or elongated nuclei with one or several delicate
nucleoli (Figure 1). They present a moderate prolifera-
tive activity that means up to three mitoses per one high
power field, the Ki-67 index was about 15%, and S-phase
fraction about 19.9%. The bladder transitional epithelium,
bordering the tumor, was normal. Immunochemically, the
tumor’s cells were positive for cytokeratins (AE1/AE3)
(Table 1), smooth muscle actin, calponin (Figure 2),
smooth muscle actin, Alk-1 antigen (Figure 3), and focally
also for desmin. The immunohistochemical reactions
against MyoD1, CD30, CD34 and miogenin (Myf-4) were
negative. To settle the diagnosis, a FISH examination with
the ALK1 break apart probe was carried out. It confirmed
the rearrangement of the chromosome 2p23 (Figure 4).
Flow cytometry analysis revealed that 67% of cells were
aneuploid (DI index was 1.12). The neoplasmatic cells
were accompanied by an abundant infiltrate of lympho-
cytes, plasmocytes and polynuclear granulocytes.
Discussion
An IMT is a relatively rare tumor. In the past, it was
described as a plasma cell granuloma, an inflammatoryTable 1 IHC staining (type of cytokeratines) IMT
presented in article
Cytokeratin Reaction
CK 7 Negative (-)
CK5/6 Negative (-)
CK 20 Negative (-)
CK 8 Negative (-)
CK 18 Negative (-)
CK 19 Negative (-)
AE1/AE3 Positive (+)proliferation of myofibroblasts or an inflammatory
pseudotumor – IPT. An IMT is usually found in chil-
dren and young adults, slightly more often in female
(F:M = 4:3) and localized mainly in the lungs, however
it may arise in almost every location. IMTs situated in
the bladder are very rare [2,5-12]. To our knowledge,
the presented case is the first IMT coexisting with the
other neoplasm. The only exception was a case of an
IMT in a patient with Recklinghausen disease, another
with systemic lupus erythematous, and the next one
with Wolf- Hirschhorn syndrome [6,9,13] (Table 2).
The first case of an IMT in the bladder was described
by Roth in 1980 [14]. The origin of this tumor was a
matter of a long debate; some authors maintained that
an IMT is a consequence of an inflammation in the
bladder, while others regarded it as a neoplastic lesion.
The Epsten-Barr virus, the human herpes virus HHV8, bac-
teria such as Campylobacter equi, Campylobacter jejuni,
Escherichia coli, trauma, radio- and steroidotherapy were
considered to be causative factors [1,2]. In some articles,
Hepatitis C, HIV and TB infections prior to theFigure 3 Alk-1 staining.
Figure 4 FISH analysis.
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http://www.diagnosticpathology.org/content/9/1/138development of pseudotumors have been documented
[2,15]. Fangusaro at al. described two cases of IMT
following hematopoetic stem cell transplantation. Both
patients received total body irradiation in preparation
for the transplant. These two cases suggest radiation as
a possible underlying cause of IMT [16]. However, more
recent research has showed that an IMT is mostTable 2 Cases of urinary bladder IMT
No of
case
Sex Age Size Clinical symptoms Immunophen
tumor cells
1 M 13 6 × 3 cm Weight loss, hematuria,
abdominal pain
CK(+), VIM(+), A

















5 M 58 3 cm hematuria, CK(-), VIM(+)





7 M 30 Nd CK(-),SMA(+), V
ALK-1(+), DES(+
Myogenin(-)
8 F 52 3 cm Painful urination CK(+), ALK-1(+)





Nd- no date available.probably a neoplasm rather than an inflammatory pseu-
dotumor; both rearrangement of 2p23 chromosome as
well as sporadic local invasion or metastases speak in
favor of neoplasmatic origin of the tumor [17,18].
Teratomas are neoplasms that arise from pluripotent
cells and can differentiate along one or more embryonic
germ lines [19,20]. Mature teratomas of the ovary are
one of the most common benign ovarian neoplasms,
accounting for approximately 10-20% of all ovarian tu-
mors. Teratoma may occur at any age in women, but
predominantly occurs in younger patients (20–40 years
old) [21]. Mature ovarian teratomas are benign ovarian
germ cell tumors that usually occur with a normal
karyotype. There are very few reports describing chromo-
somal abnormalities in these tumors, none of which are
recurrent. The Ding Y study in 2011 was the first to dem-
onstrate the differential profile of 16 miRNAs in mature
ovarian teratomas. An aberrant expression of miRNAs
may be essential for the pathogenesis of mature ovarian
teratomas [22].
An IMT may occur in the bladder at any age (from
childhood to old age) [23,24]. This rare disease does not
usually cause pain; the most frequent symptoms are se-
vere hematuria, sometimes anuria and a palpable tumor.
The tumor may be localized in any region of the bladder,otype of First diagnosis FISH Follow up No of
(art.)
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http://www.diagnosticpathology.org/content/9/1/138however the trigone of the bladder has never been af-
fected, apart of the cases where the tumor arose in the
posterior wall of the bladder and secondarily infiltrated
the trigone [23]. The size of the tumor is variable – from
several centimeters up to 37.5 cm [25]. Obviously, it is
not possible to distinguish an IMT from malignant
tumors of the bladder with diagnostic methods such as
an RTG or endoscopy. Macroscopically, these tumors
are well circumscribed, light and soft; the cut surface is
smooth, occasionally opalescent, without hemorrhagic
foci or necrosis [25].
Histologically, it is possible to distinguish three types
of these tumors: the vascular-myxoidal type, which can
resemble nodular fasciitis or granulomatous tissue; the
solid, spindle-cell type, which resembles a fibrous his-
tiocytoma or tumor originating from smooth muscle
or a low-cellular-fibrous, which imitates desmoids or a
scar [2,8,26].
The key criteria in IMT diagnostics are: proliferation
of myoepithelial spindle cells accompanied by lymphocytic
infiltration of tumor stroma, the positive immunohisto-
chemical reaction to ALK-1, vimentin and cytokeratin
[27,28], and finally ALK1 gene rearrangement confirmed
cytogenetically or by FISH method. It shows the re-
arrangement of the ALK gene in the population of spindle
cells in an IMT [26]. The ALK gene is located on the 2p23
chromosome; it encodes the ALK protein, the tyrosine
kinase receptor. This method is a very sensitive tool used
to differentiate an IMT from other spindle-cell tumors of
the bladder. In IMT tumors, the positive immunohisto-
chemical reaction with an antibody against ALK-1 is ob-
served in more than 60% cases, while in the FISH
method it is observed in almost 70% of the cases. Over-
expression of this gene is also observed in anaplastic
large cell lymphoma [29]. Some IMTs show an expres-
sion of cytokeratins, SMA or desmin [18,27]. Myogenin,
a rhabdomyosarcoma marker, allows this tumor to be
excluded [30].
Morphologic and immunophenotypic similarities be-
tween an IMT and other malignant tumors of the bladder
may lead to diagnostic errors and an unnecessary radical
cystectomy as a result.
The misdiagnosis of an IMT as a rhabdomyosarcoma, a
leiomyosarcoma or a sarcomatoid urothelial carcinoma,
and as a result, unnecessary radical surgery, adjuvant
therapy and its complications, is a major problem of
contemporary IMT diagnostics.
Conclusions
IMT-type tumors belong to neoplasms of an intermediate
biologic potential with a considerable rate of local recur-
rence and in some cases they are able to create metastases
[31]. In the case described in this paper, the presence of a
large necrosis in the central portion of the tumor, mitoticactivity and the presence of aneuploidal cells (seen in cyto-
fluorometry) suggest a more aggressive type of IMT. The
therapy of choice is the total excision of the tumor, a rad-
ical cystectomy is not necessary [32,33].
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